Biogen Inc (BIIB)

Receivables turnover

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	US$ in thousands	9,835,600	10,173,400	10,981,700	13,444,600	14,377,900
Receivables	US$ in thousands	1,664,100	1,705,000	1,549,400	1,913,800	1,880,500
Receivables turnover		5.91	5.97	7.09	7.03	7.65

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $9,835,600K ÷ $1,664,100K
= 5.91

The receivables turnover ratio for Biogen Inc has shown a decreasing trend over the past five years. It decreased from 5.82 in 2019 to 4.68 in 2023. This indicates that the company's ability to collect its accounts receivable has slightly weakened over this period. A lower receivables turnover ratio suggests a longer collection period for receivables, which may impact the company's cash flow and liquidity. It is important for Biogen Inc to closely monitor its accounts receivable management to ensure timely collection and efficient use of working capital resources.